Chronic and acute effects of different antihypertensive drugs on femoral artery relaxation of L-NAME hypertensive rats

Physiological Research

Volumn 56, Issue SUPPL. 2, 2007, Pages

  Sladkova M ^a   Kojsova S ^a   Jendekova L ^a   Pechanova O ^a,b  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Captopril; Femoral artery; Hydrochlorothiazide; Indapamide; L NAME induced hypertension; Vasorelaxation

Indexed keywords

ACETYLCHOLINE; ANTIHYPERTENSIVE AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; INDAPAMIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; VASODILATOR AGENT;

ANIMAL; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DISEASE MODEL; DRUG ADMINISTRATION; DRUG COMBINATION; DRUG EFFECT; DRUG POTENTIATION; FEMORAL ARTERY; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE; HYPERTENSION; METABOLISM; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; RAT; VASODILATATION; WISTAR RAT;

ACETYLCHOLINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BODY WEIGHT; CAPTOPRIL; DISEASE MODELS, ANIMAL; DIURETICS; DRUG ADMINISTRATION SCHEDULE; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMORAL ARTERY; HEART VENTRICLES; HYDROCHLOROTHIAZIDE; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INDAPAMIDE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; ORGAN SIZE; RATS; RATS, WISTAR; VASODILATION; VASODILATOR AGENTS;

EID: 38549142778     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. BERNÁTOVÁ I, PECHÁŇOVÁ O, ŠIMKO F: Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats. Physiol Res 45: 311-316, 1996.
2. BERNÁTOVÁ I, PECHÁŇOVÁ O, PELOUCH V, ŠIMKO F: Regression of chronic L-NAME-treatment-induced left ventricular hypertrophy: effect of captopril. J Mol Cell Cardiol 32: 177-185, 2000.
3. BOULANGER CM, MOMBOULI JV, VANHOUTTE PM: Indapamide inhibits endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Fundam Clin Pharmacol 7: 443-448, 1993.
4. COHN JN: Arterial compliance to stratify cardiovascular risk: more precision in therapeutic decision making. Am J Hypertens 14 (8 Part 2): 258S-263S, 2001.
5. DAHLOF B, HANSSON L: The influence of antihypertensive therapy on the structural arteriolar changes in essential hypertension: different effects of enalapril and hydrochlorothiazide. J Intern Med 234: 271-279, 1993.
6. 10 level, improved respiratory chain function and energy production in the left ventricle in rabbits with smoke mitochondrial cardiomyopathy. Biofactors 10: 61-65, 1999.
7. HAYAKAWA H, COFFEE K, RAIJ L: Endothelial dysfunction and cardiorenal injury in experimental salt-sensitive hypertension: effects of antihypertensive therapy. Circulation 96: 2407-2413, 1997.
8. JOHNS DW, AYERS CR, WILLIAMS SC: Dilation of forearm blood vessels after angiotensin-converting-enzyme inhibition by captopril in hypertensive patients. Hypertension 6: 545-550, 1984.
9. KEATON AK, WHITE CR, BERECEK KH: Captopril treatment and its withdrawal prevents impairment of endothelium-dependent responses in the spontaneously hypertensive rat. Clin Exp Hypertens 20: 847-866, 1998.
10. KOJŠOVÁ S, JENDEKOVÁ L, CSIZMADIOVÁ Z, VRANKA I, JANÍKOVÁ R, PECHÁŇOVÁ O: The effect of indapamide and captopril on blood pressure, nitric oxide generation and oxidant status in spontaneously hypertensive rats. Physiol Res 54: 54P, 2005.
11. KOJŠOVÁ S, JENDEKOVÁ L, SLÁDKOVÁ M, CSIZMADIOVÁ Z, PAULIS ?, PECHÁŇOVÁ O: Different effects of indapamide and hydrochlorothiazide treatment on spontaneous and L-NAME-induced hypertension. Physiol Res 55: 6P, 2006.
12. KOJŠOVÁ S, JENDEKOVÁ L, ZICHA J, KUNEŠ J, ANDRIANTSITOHAINA R, PECHÁŇOVÁ O: The effect of different antioxidants on nitric oxide production in hypertensive rats. Physiol Res 55 (Suppl 1): S3-S16, 2006.
13. KONSTAM MA, PATTEN RD, THOMAS I, RAMAHI T, LA BRESH K, GOLDMAN S, LEWIS W, GRADMAN A, SELF KS, BITTNER V, RAND W, KINAN D, SMITH JJ, FORD T, SEGAL R, UDELSON JE: Effects of losartan and captoprilon left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy. Am Heart J 139: 1081-1087, 2000.
14. KRISTEK F, KOPRDOVÁ R, CEBOVÁ M: Long-term effects of early administered sildenafil and NO donor on the cardiovascular system of SHR. J Physiol Pharmacol 58: 33-43, 2007.
15. LEVY BI, POITEVIN P, SAFAR ME: Effects of indapamide on the mechanical properties of the arterial wall in deoxycorticosterone acetate-salt hypertensive rats. Am J Cardiol 65 (17): 28H-32H, 1990.
16. MANLEY HJ: Role of angiotensin-converting-enzyme inhibition in patients with renal disease. Am J Health Syst Pharm 57 (Suppl 1): S12-S18, 2000.
17. PECHÁŇOVÁ O: Contribution of captopril thiol group to the prevention of spontaneous hypertension Physiol Res 56 (Suppl 2): S41-S48, 2007.
18. PECHÁŇOVÁ O, BERNÁTOVÁ I, PELOUCH V, ŠIMKO F: Protein remodelling of the heart in NO-deficient hypertension: the effect of captopril. J Mol Cell Cardiol 29: 3365-3374, 1997.
19. PECHÁŇOVÁ O, MATUŠKOVÁ J, CAPÍKOVÁ D, JENDEKOVÁ L, PAULIS L, ŠIMKO F: Effect of spironolactone and captopril on nitric oxide and S-nitrosothiol formation in kidney of L-NAME-treated rats. Kidney Int 70: 170-176, 2006.
20. PICKKERS P, HUGHES AD, RUSSEL FGM, THIEN T, SMITS P: Thiazide-induced vasodilation in humans is mediated by potassium channel activaton. Hypertension 32: 1071-1076, 1998.
21. ŠIMKO F: Physiologic and pathologic myocardial hypertrophy-physiologic and pathologic regression of hypertrophy? Med Hypotheses 58: 11-14, 2002.
22. ŠIMKO F: Is NO the king? Pathophysiological benefit with uncertain clinical impact. Physiol Res 56 (Suppl 2): S1-S6, 2007.
23. ŠIMKO F, ŠIMKO J: Heart failure and angiotensin converting enzyme inhibition: problems and perspectives. Physiol Res 48: 1-8, 1999.
24. ŠIMKO F, MARTINKA P, BRASSANOVÁ J, KLIMAŠ J, GVOZDJÁKOVÁ A, KUCHARSKÁ J, BADA V, HULÍN I, KYSELOVIČ J: Passive cigarette smoking induced changes in reactivity of the aorta in rabbits: efffect of captopril. Pharmazie 56: 431-432, 2001.
25. ŠIMKO F, ŠIMKO J, FABRYOVÁ M: ACE-inhibition and angiotensin II receptor blockers in chronic heart failure: pathophysiological consideration of the unresolved battle. Cardiovasc Drugs Ther 17: 287-90, 2003.
26. SLÁDKOVÁ M, KOJŠOVÁ S, PECHÁŇ OVÁ O: Effect of chronic indapamide, hydrochlorothiazide and captopril treatment on relaxation of femoral artery in spontaneously hypertensive rats. Physiol Res 54: 57P, 2005.
27. SLÁDKOVÁ M, KOJŠOVÁ S, PECHÁŇ OVÁ O: Comparison of femoral artery relaxation after acute and chronic administration of indapamide, hydrochlorothiazide and captopril in spontaneously hypertensive rats. Physiol Res 55: 10P, 2006.
28. SZILVASSY Z, CSONT T, PALIC T, DROY-LEFAIX M, FERDINANDY P: Nitric oxide, peroxynitrite and cGMP in atherosclerosis-induced hypertension in rabbits: beneficial effects of cicletanine. J Vasc Res 38: 39-46, 2001.
29. TOBLLI JE, DEROSA G, RIVAS C, CAO G, PIORNO P, PAGANO P, FORCADA P: Cardiovascular protective role of a low-dose antihypertensive combination in obese Zucker rats. J Hypertens 21: 611-620, 2003.
30. TÖRÖK J, BABÁL P, MATUŠKOVÁ J, LUPTÁK I, KLIMEŠ I, ŠIMKO F: Impaired endothelial function of thoracic aorta in hereditary hypertriglyceridemic rats. Ann N Y Acad Sci 967: 469-475, 2002.
31. UEHARA Y, SHIRAHASE H, NAGATA T, ISHIMITSU T, MORISHITA S, OSUMI S, MATSUOKA H, SUGIMOTO T: Radical scavengers of indapamide in prostacyclin synthesis in rat smooth muscle cell. Hypertension 15: 216-224, 1990.
32. WIEMER G, LINZ W, HATRIK S, SCHOLKENS BA, MALINSKI T: Angiotensin-converting enzyme inhibition alters nitric oxide and superoxide release in normotensive and hypertensive rats. Hypertension 30: 1183-1190, 1997.
33. ZICHA J, DOBEŠOVÁ Z, KUNEŠ J: Antihypertensive mechanisms of chronic captopril or N-acetylcysteine treatment in L-NAME hypertensive rats. Hypertens Res 29: 1021-1027, 2006a.
34. ZICHA J, PECHÁŇOVÁ O, ČAČÁ NYIOVÁ S, CEBOVÁ M, KRISTEK F, TÖRÖK J, ŠIMKO F, DOBEŠOVÁ Z, KUNEŠ J: Hereditary hypertriglyceridemic rat: a suitable model of cardiovascular disease and metabolic syndrome? Physiol Res 55 (Suppl 1): S49-63, 2006b.